1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Belgium >
  5. bioMerieux Acquires Applied Maths NV

M&A Deal Summary

bioMerieux Acquires Applied Maths NV

On January 5, 2016, bioMerieux acquired software company Applied Maths NV

Acquisition Highlights
  • This is bioMerieux’s 1st transaction in the Software sector.
  • This is bioMerieux’s 1st transaction in Belgium.

M&A Deal Summary
Date 2016-01-05
Target Applied Maths NV
Sector Software
Buyer(s) bioMerieux
Deal Type Add-on Acquisition

Target

Applied Maths NV

Sint-Martens-Latem, Belgium
Applied Maths NV a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data. Applied Maths develops and commercializes BioNumerics universal software for microbiology applications, including in bacteriology, virology and mycology.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

bioMerieux

Marcy l'Etoile, France
Category Company
Founded 1963
Sector Life Science
Employees14,147
Revenue 4.0B EUR (2024)
DESCRIPTION

bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.

DEAL STATS #
Overall 18 of 21
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 15 of 17
Country: Belgium M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-22 CEERAM S.A.S.

La Chapelle sur Erdre, France

CEERAM S.A.S. is a molecular virology laboratory specialized in the detection of foodborne and environmental viruses.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-09 Suzhou Hybiome Biomedical Engineering Co.

Suzhou, China

Suzhou Hybiome Biomedical Engineering Co.Ltd. is specialized in automated immunoassay tests. The company develops, manufactures and markets a complete range of diagnostic solutions (reagents, instruments, and software) cleared by the China Food and Drug Administration (CFDA). Hybiome markets two automated, mid-throughput immunoassay systems (AE-180 and AE-240) using the latest generation CLIA1 technology and featuring a menu of nearly 80 parameters. Hybiome also recently received CFDA clearance for the AE-120 system, to further increase access to its menu of assays. Hybiome’s installed base has about 1,000 active instruments that are used primarily in medium-sized hospitals (100 to 500 beds), known as Grade 2 facilities.

Buy -
Mergr

Solution for

Product

Company

Legal